Professor Nada Hamad

Prof Nada Hamad is a haematologist and clinician researcher in cellular therapy, including CAR T and stem cell transplantation. She is President and Chair of the Board of ANZTCT (Australia and New Zealand Transplant and Cellular Therapies), the peak body and national clinical quality registry for transplant and cellular therapy in Australia and New Zealand, Conjoint Professor at UNSW Sydney, Adjunct Professor at the University of Notre Dame Australia and a Fulbright Senior Scholar.

Her research looks at access to and outcomes of advanced therapies, using real world data to show where health systems fall short and how to close those gaps. Her focus areas are lymphoma, clinical trials, health equity, health policy and AI in health care. She has published in journals including the New England Journal of Medicine, Nature Medicine, JAMA, Journal of Clinical Oncology, Lancet Haematology and Blood, and has been a Chief Investigator on more than $4 million in competitive research funding.

She is the Australian representative on the WHO Bone Marrow Transplantation Taskforce and an Associate Editor of JCO Global Oncology. She supervises ILP, Honours and HDR students and is committed to mentoring the next generation of clinician researchers.